BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 22939943)

  • 1. Osteocyte control of osteoclastogenesis.
    O'Brien CA; Nakashima T; Takayanagi H
    Bone; 2013 Jun; 54(2):258-63. PubMed ID: 22939943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption.
    Kitaura H; Marahleh A; Ohori F; Noguchi T; Shen WR; Qi J; Nara Y; Pramusita A; Kinjo R; Mizoguchi I
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway.
    Wijenayaka AR; Kogawa M; Lim HP; Bonewald LF; Findlay DM; Atkins GJ
    PLoS One; 2011; 6(10):e25900. PubMed ID: 21991382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6 Enhances Osteocyte-Mediated Osteoclastogenesis by Promoting JAK2 and RANKL Activity In Vitro.
    Wu Q; Zhou X; Huang D; Ji Y; Kang F
    Cell Physiol Biochem; 2017; 41(4):1360-1369. PubMed ID: 28278513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High mobility group box 1 protein regulates osteoclastogenesis through direct actions on osteocytes and osteoclasts in vitro.
    Davis HM; Valdez S; Gomez L; Malicky P; White FA; Subler MA; Windle JJ; Bidwell JP; Bruzzaniti A; Plotkin LI
    J Cell Biochem; 2019 Oct; 120(10):16741-16749. PubMed ID: 31106449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scl-Ab reverts pro-osteoclastogenic signalling and resorption in estrogen deficient osteocytes.
    Allison H; Holdsworth G; McNamara LM
    BMC Mol Cell Biol; 2020 Nov; 21(1):78. PubMed ID: 33148174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoclast differentiation by RANKL and OPG signaling pathways.
    Udagawa N; Koide M; Nakamura M; Nakamichi Y; Yamashita T; Uehara S; Kobayashi Y; Furuya Y; Yasuda H; Fukuda C; Tsuda E
    J Bone Miner Metab; 2021 Jan; 39(1):19-26. PubMed ID: 33079279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of TNF-
    Ohori F; Kitaura H; Marahleh A; Kishikawa A; Ogawa S; Qi J; Shen WR; Noguchi T; Nara Y; Mizoguchi I
    J Immunol Res; 2019; 2019():9716758. PubMed ID: 31341915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory mechanisms of RANKL presentation to osteoclast precursors.
    Honma M; Ikebuchi Y; Kariya Y; Suzuki H
    Curr Osteoporos Rep; 2014 Mar; 12(1):115-20. PubMed ID: 24477414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RANKL subcellular trafficking and regulatory mechanisms in osteocytes.
    Honma M; Ikebuchi Y; Kariya Y; Hayashi M; Hayashi N; Aoki S; Suzuki H
    J Bone Miner Res; 2013 Sep; 28(9):1936-49. PubMed ID: 23529793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron Overload-Induced Osteocyte Apoptosis Stimulates Osteoclast Differentiation Through Increasing Osteocytic RANKL Production In Vitro.
    Yang J; Dong D; Luo X; Zhou J; Shang P; Zhang H
    Calcif Tissue Int; 2020 Nov; 107(5):499-509. PubMed ID: 32995951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zoledronate Enhances Osteocyte-Mediated Osteoclast Differentiation by IL-6/RANKL Axis.
    Kim HJ; Kim HJ; Choi Y; Bae MK; Hwang DS; Shin SH; Lee JY
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-α Directly Enhances Osteocyte RANKL Expression and Promotes Osteoclast Formation.
    Marahleh A; Kitaura H; Ohori F; Kishikawa A; Ogawa S; Shen WR; Qi J; Noguchi T; Nara Y; Mizoguchi I
    Front Immunol; 2019; 10():2925. PubMed ID: 31921183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lenalidomide regulates osteocytes fate and related osteoclastogenesis via IL-1β/NF-κB/RANKL signaling.
    Qu X; Mei J; Yu Z; Zhai Z; Qiao H; Dai K
    Biochem Biophys Res Commun; 2018 Jun; 501(2):547-555. PubMed ID: 29746861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vibration enhances osteoclastogenesis by inducing RANKL expression via NF-κB signaling in osteocytes.
    Sakamoto M; Fukunaga T; Sasaki K; Seiryu M; Yoshizawa M; Takeshita N; Takano-Yamamoto T
    Bone; 2019 Jun; 123():56-66. PubMed ID: 30902792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteocyte RANKL Drives Bone Resorption in Mouse Ligature-Induced Periodontitis.
    Kittaka M; Yoshimoto T; Levitan ME; Urata R; Choi RB; Teno Y; Xie Y; Kitase Y; Prideaux M; Dallas SL; Robling AG; Ueki Y
    J Bone Miner Res; 2023 Oct; 38(10):1521-1540. PubMed ID: 37551879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fluoride on osteocyte-driven osteoclastic differentiation.
    Jiang N; Guo F; Xu W; Zhang Z; Jin H; Shi L; Zhang X; Gao J; Xu H
    Toxicology; 2020 Apr; 436():152429. PubMed ID: 32156525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteocytes produce interferon-β as a negative regulator of osteoclastogenesis.
    Hayashida C; Ito J; Nakayachi M; Okayasu M; Ohyama Y; Hakeda Y; Sato T
    J Biol Chem; 2014 Apr; 289(16):11545-11555. PubMed ID: 24610813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteocytes as mechanosensors in the inhibition of bone resorption due to mechanical loading.
    You L; Temiyasathit S; Lee P; Kim CH; Tummala P; Yao W; Kingery W; Malone AM; Kwon RY; Jacobs CR
    Bone; 2008 Jan; 42(1):172-9. PubMed ID: 17997378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6 exhibits both
    McGregor NE; Murat M; Elango J; Poulton IJ; Walker EC; Crimeen-Irwin B; Ho PWM; Gooi JH; Martin TJ; Sims NA
    J Biol Chem; 2019 May; 294(19):7850-7863. PubMed ID: 30923130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.